Manufacture/distributor BR-PH
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2D222D0146
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Task orders
- 0
Award facts
- Opportunity
-
- Levalbuterol HCL Solution Pre-Solicitation · SPE2D221R0116 · Posted Sep 30, 2021
- Last date to order 84% complete
- IDV ceiling
- $5,687,207.30
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Teva Pharmaceuticals USA, Inc. was awarded a single-award Indefinite Delivery Contract valued at $5.69 million by the Defense Logistics Agency (DLA) Troop Support Medical, effective August 31, 2022, through August 30, 2027. This contract establishes Teva as the national prime vendor for Levalbuterol HCL Solution, a bronchodilator medication used in respiratory treatment. The contract encompasses a no-set-aside procurement and was preceded by a pre-solicitation notice posted on September 30, 2021. As the sole awardee, Teva is responsible for manufacturing and distributing Levalbuterol HCL Solution to support the pharmaceutical supply requirements of multiple federal healthcare agencies, including the Department of Defense, Veterans Affairs, Federal Bureau of Prisons, and Indian Health Service.
The contract structure as a single-award Indefinite Delivery Vehicle provides these federal agencies with a streamlined procurement mechanism for obtaining critical respiratory pharmaceutical products with predetermined pricing and delivery terms. Teva's role as national prime vendor ensures supply chain continuity and reliability for Levalbuterol HCL Solution across the federal government's healthcare system. This procurement aligns with the Defense Logistics Agency's mission to supply medical products to military and civilian federal healthcare programs. The five-year performance period reflects the long-term nature of pharmaceutical supply contracts, enabling federal agencies to maintain adequate inventory levels of essential respiratory medications while providing Teva with predictable demand forecasting across multiple customer agencies.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Change Order | $0 | |
| Exercise an Option | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Change Order | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract SPE2D222D0146?
SPE2D222D0146 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on August 31, 2022.
How much is contract SPE2D222D0146 worth?
SPE2D222D0146's own ceiling is $5,687,207.
Who can order from contract SPE2D222D0146?
SPE2D222D0146 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2D222D0146 competed?
The extent of competition for SPE2D222D0146 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV